References
- Agresti, A. and M. Kateri. 2011. Categoricaldata analysis. Springer Berlin Heidelberg, Berlin, Germany.
- Arce, C., M. Ramirez-Boo, C. Lucena, and J. J. Garrido. 2010. Innate immune activation of swine intestinal epithelial cell lines (IPEC-J2 and IPI-2I) in response to LPS from Salmonella typhimurium. Comp. Immunol. Microbiol. Dis. 33:161-174. https://doi.org/10.1016/j.cimid.2008.08.003
- Cameron, H. L. and M. H. Perdue. 2005. Stress impairs murine intestinal barrier function: Improvement by glucagon-like peptide-2. J. Pharmacol. Exp. Ther. 314:214-220. https://doi.org/10.1124/jpet.105.085373
- Cheeseman, C. I. 1997. Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo. Am. J. Physiol. Regul. Integr. Comp. Physiol. 273:R1965-R1971. https://doi.org/10.1152/ajpregu.1997.273.6.R1965
- Chen, Z. Y., X. S. Feng, and P. Yang. 2008. Effect of glucagon-like peptide-2 on modulation of intestinal epithelium tight junction in rats with obstructive jaundice. Chin. J. Gen. Surg. 17:760-763.
- Dong, C. X., W. Zhao, C. Solomon, K. J. Rowland, C. Ackerley, S. Robine, and P. L. Brubaker. 2013. The intestinal epithelial insulin-like growth factor-1 receptor links glucagon-like peptide-2 action to gut barrier function. Endocrinology 155:370-379.
- Geens, M. M. and T. A. Niewold. 2010. Preliminary characterization of the transcriptional response of the porcine intestinal cell line IPEC-J2 to enterotoxigenic Escherichia coli, Escherichia coli, and E. coli lipopolysaccharide. Comp. Funct. Genomics 2010: Article ID 469583.
- Guo, S., R. Al-Sadi, H. M. Said, and T. Y. Ma. 2013. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am. J. Pathol. 182:375-387. https://doi.org/10.1016/j.ajpath.2012.10.014
- Gonzalez-Mariscal, L., R. Tapia, and D. Chamorro. 2008. Crosstalk of tight junction components with signaling pathways. Biochem. Biophys. Acta-Biomembranes 1778:729-756. https://doi.org/10.1016/j.bbamem.2007.08.018
- Hu, C. H., K. Xiao, Z. S. Luan, and J. Song. 2013. Early weaning increases intestinal permeability, alters expression of cytokine and tight junction proteins, and activates mitogen-activated protein kinases in pigs. J. Anim. Sci. 91:1094-1101. https://doi.org/10.2527/jas.2012-5796
- Hou, Y., L. Wang, W. Zhang, Z. Yang, B. Ding, H. Zhu, and G. Wu. 2012. Protective effects of N-acetylcysteine on intestinal functions of piglets challenged with lipopolysaccharide. Amino Acids 43:1233-1242. https://doi.org/10.1007/s00726-011-1191-9
- Koehler, J. A., W. Harper, M. Barnard, B. Yusta, and D. J. Drucker. 2008. Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells. Cancer Res. 68:7897-7904. https://doi.org/10.1158/0008-5472.CAN-08-0029
- Li. Q., Y. Liu, Z. Che, H. Zhu, G. Meng, Y. Hou, and F. Chen. 2012. Dietary L-arginine supplementation alleviates liver injury caused by Escherichia coli LPS in weaned pigs. Innate Immun. 18:804-814. https://doi.org/10.1177/1753425912441955
- Liu, Y., J. Huang, Y. Hou, H. Zhu, S. Zhao, B. Ding, and W. Fan. 2008. Dietary arginine supplementation alleviates intestinal mucosal disruption induced by Escherichia coli lipopolysaccharide in weaned pigs. Br. J. Nutr. 100:552-560. https://doi.org/10.1017/S0007114508911612
-
Moran, G. W., C. O'Neill, and J. T. McLaughlin. 2012. GLP-2 enhances barrier formation and attenuates
$TNF{\alpha}$ -induced changes in a Caco-2 cell model of the intestinal barrier. Regul. Pept. 178:95-101. https://doi.org/10.1016/j.regpep.2012.07.002 - Naimi, R. M., K. B. Madsen, C. Askov-Hansen, C. F. Brandt, B. Hartmann, J. J. Holst, and P. B. Jeppesen. 2013. A doseequivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patients. Regul. Pept. 184:47-53. https://doi.org/10.1016/j.regpep.2013.03.023
- Niessen, C. M. and C. J. Gottardi. 2008. Molecular components of the adherens junction. Biochem. Biophys. Acta-Biomembranes 1778:562-571. https://doi.org/10.1016/j.bbamem.2007.12.015
- Paszti-Gere, E., G. Matis, O. Farkas, A. Kulcsar, O. Palocz, G. Csiko, and P. Galfi. 2014. The effects of intestinal LPS exposure on inflammatory responses in a porcine enterohepatic co-culture system. Inflammation 37:247-260. https://doi.org/10.1007/s10753-013-9735-7
- Pfaffl, M. W. 2001. A new mathematical model for relative quantification in real time RT-PCR. Nucl. Acids Res. 29:e45. https://doi.org/10.1093/nar/29.9.e45
- Razzuoli, E., R. Villa, and M. Amadori. 2013. IPEC-J2 cells as reporter system of the anti-inflammatory control actions of interferon-alpha. J. Interferon. Cytokine Res. 33:597-605. https://doi.org/10.1089/jir.2012.0127
- Smith, F., J. E. Clark, B. L. Overman, C. C. Tozel, J. H. Huang, J. E. Rivier, and A. J. Moeser. 2010. Early weaning stress impairs development of mucosal barrier function in the porcine intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 298:G352-G363. https://doi.org/10.1152/ajpgi.00081.2009
- Sigalet, D. L., E. de Heuvel, L. Wallace, E. Bulloch, J. Turner, P. Nation, and J. J. Holst. 2014. Effects of chronic glucagon-like peptide-2 therapy during weaning in neonatal pigs. Regul. Pept. 188:70-80. https://doi.org/10.1016/j.regpep.2013.12.006
- Shi, X., F. Zhou, X. Li, B. Chang, D. Li, Y. Wang, and X. Guan. 2013. Central GLP-2 enhances hepatic insulin sensitivity via activating PI3K signaling in POMC neurons. Cell Metabol. 18:86-98. https://doi.org/10.1016/j.cmet.2013.06.014
- Shi, X., X. Li, Y. Wang, K. Zhang, F. Zhou, L. Chan, and X. Guan. 2011. Glucagon-like peptide-2-stimulated protein synthesis through the PI 3-kinase-dependent Akt-mTOR signaling pathway. Am. J. Physiol. Endocrinol. Metab. 300:E554-E563. https://doi.org/10.1152/ajpendo.00620.2010
- Thymann, T., I. Le Huërou-Luron, Y. M. Petersen, M. S. Hedemann, J. Elinf, B. B. Jensen, and P. T. Sangild. 2014. Glucagon-like peptide 2 treatment may improve intestinal adaptation during weaning. J. Anim. Sci. 92:2070-2079. https://doi.org/10.2527/jas.2013-7015
- Wijtten, P. J., J. van der Meulen, and M. W. Verstegen. 2011. Intestinal barrier function and absorption in pigs after weaning: A review. Br. J. Nutr. 105:967-981. https://doi.org/10.1017/S0007114510005660
- Yusta, B., J. Estall, and D. J. Drucker. 2002. Glucagon-like peptide-2 receptor activation engages bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 27:24896-24906.
- Zhao, Y., G. Qin, Z. Sun, D. Che, N. Bao, and X. Zhang. 2011. Effects of soybean agglutinin on intestinal barrier permeability and tight junction protein expression in weaned piglets. Int. J. Mol. Sci. 12:8502-8512. https://doi.org/10.3390/ijms12128502
Cited by
- signalling pathway vol.101, pp.6, 2017, https://doi.org/10.1111/jpn.12644
- Growth factors and their use in short bowel vol.33, pp.3, 2017, https://doi.org/10.1097/MOG.0000000000000351
- Gene expression and morphological changes in the intestinal mucosa associated with increased permeability induced by short-term fasting in chickens pp.09312439, 2017, https://doi.org/10.1111/jpn.12808
- Glucagon-Like Peptide-2 Improve Intestinal Mucosal Barrier Function in Aged Rats vol.22, pp.6, 2018, https://doi.org/10.1007/s12603-018-1022-8
- Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans vol.136, pp.12, 2016, https://doi.org/10.1182/blood.2020005957
- Perspective: Prospects for Nutraceutical Support of Intestinal Barrier Function vol.12, pp.2, 2016, https://doi.org/10.1093/advances/nmaa139
- Gut microbiome, prebiotics, intestinal permeability and diabetes complications vol.35, pp.3, 2016, https://doi.org/10.1016/j.beem.2021.101507